The present findings further elucidated the mechanism of PDIA3 and ATF2 in ox-LDL-stimulated HUVECs and provided insights into the potential of targeting these two genes in the treatment of atherosclerosis. This evidence concerns the gene ATF2 and atherosclerosis.